Tomas Norman Dam

907 total citations
25 papers, 710 citations indexed

About

Tomas Norman Dam is a scholar working on Immunology, Dermatology and Oncology. According to data from OpenAlex, Tomas Norman Dam has authored 25 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 9 papers in Dermatology and 7 papers in Oncology. Recurrent topics in Tomas Norman Dam's work include Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Tomas Norman Dam is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (6 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Tomas Norman Dam collaborates with scholars based in Denmark, United States and Netherlands. Tomas Norman Dam's co-authors include Lone Skov, Frederik Dagnæs‐Hansen, Arnout F. Gerritsen, Louise S. Villadsen, Jan G. J. van de Winkel, Ole Baadsgaard, Paul W.H.I. Parren, Marc A. van Dijk, Janine Schuurman and Marleen M. Voorhorst‐Ogink and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Tomas Norman Dam

25 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Norman Dam Denmark 14 491 180 148 116 69 25 710
Anna López‐Ferrer Spain 19 630 1.3× 303 1.7× 260 1.8× 84 0.7× 179 2.6× 55 935
Nicholas V.C. Chia United States 4 672 1.4× 295 1.6× 88 0.6× 123 1.1× 115 1.7× 8 799
Laura F. Morris United States 8 436 0.9× 181 1.0× 70 0.5× 78 0.7× 94 1.4× 10 663
Emanuela Campalani United Kingdom 8 374 0.8× 167 0.9× 165 1.1× 78 0.7× 103 1.5× 14 593
David Soler United States 12 249 0.5× 114 0.6× 134 0.9× 94 0.8× 35 0.5× 26 505
Maria Yhr Sweden 12 476 1.0× 194 1.1× 187 1.3× 110 0.9× 84 1.2× 15 671
Elyssa Ott United States 9 199 0.4× 71 0.4× 88 0.6× 85 0.7× 54 0.8× 14 491
Julie Parmentier United States 8 136 0.3× 120 0.7× 85 0.6× 165 1.4× 185 2.7× 18 598
Dingyao Zhang United States 8 218 0.4× 86 0.5× 211 1.4× 53 0.5× 226 3.3× 15 637
John C. Minnerly United States 8 229 0.5× 57 0.3× 153 1.0× 232 2.0× 278 4.0× 11 745

Countries citing papers authored by Tomas Norman Dam

Since Specialization
Citations

This map shows the geographic impact of Tomas Norman Dam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Norman Dam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Norman Dam more than expected).

Fields of papers citing papers by Tomas Norman Dam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Norman Dam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Norman Dam. The network helps show where Tomas Norman Dam may publish in the future.

Co-authorship network of co-authors of Tomas Norman Dam

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Norman Dam. A scholar is included among the top collaborators of Tomas Norman Dam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Norman Dam. Tomas Norman Dam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dam, Tomas Norman, et al.. (2024). Medical specialists’ use and opinion of video consultation in Denmark: a survey study. BMC Health Services Research. 24(1). 516–516. 1 indexed citations
2.
Rasmussen, Mads Kirchheiner, Trine Bertelsen, Tomas Norman Dam, et al.. (2023). Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study. Journal of the American Academy of Dermatology. 88(6). 1378–1381. 5 indexed citations
3.
Loft, Nikolai, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.. (2023). Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study. Acta Dermato Venereologica. 103. adv12616–adv12616. 3 indexed citations
4.
Du, Amy, Zarqa Ali, Tomas Norman Dam, et al.. (2023). Machine learning model for predicting outcomes of biologic therapy in psoriasis. Journal of the American Academy of Dermatology. 88(6). 1364–1367. 12 indexed citations
5.
Loft, Nikolai, Mads Kirchheiner Rasmussen, C. Nissen, et al.. (2021). Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study. Acta Dermato Venereologica. 101(10). adv00579–adv00579. 26 indexed citations
6.
Loft, Nikolai, Lone Skov, Mads Kirchheiner Rasmussen, et al.. (2018). Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis. PLoS ONE. 13(2). e0192010–e0192010. 29 indexed citations
7.
Stenderup, Karin, Cecilia Rosada, Kurt Shanebeck, et al.. (2015). AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use—improves psoriasis in a human xenograft transplantation model. Protein Engineering Design and Selection. 28(10). 467–480. 14 indexed citations
8.
Stenderup, Karin, et al.. (2013). Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin diseases.. PubMed. 12(10). 1156–62. 2 indexed citations
9.
Ahlehoff, Ole, Lone Skov, Gunnar Gislason, et al.. (2012). Pharmacological Undertreatment of Coronary Risk Factors in Patients with Psoriasis: Observational Study of the Danish Nationwide Registries. PLoS ONE. 7(4). e36342–e36342. 44 indexed citations
10.
Bak, Rasmus O., Karin Stenderup, Cecilia Rosada, et al.. (2011). Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic skin. BMC Dermatology. 11(1). 5–5. 20 indexed citations
11.
Stenderup, Karin, et al.. (2011). Statistical evaluation and experimental design of a psoriasis xenograft transplantation model treated with cyclosporin A. Experimental Dermatology. 20(5). 441–444. 7 indexed citations
12.
Jakobsen, Maria, Karin Stenderup, Cecilia Rosada, et al.. (2009). Amelioration of Psoriasis by Anti-TNF-α RNAi in the Xenograft Transplantation Model. Molecular Therapy. 17(10). 1743–1753. 62 indexed citations
13.
Rosada, Cecilia, et al.. (2009). Valrubicin in a Topical Formulation Treats Psoriasis in a Xenograft Transplantation Model. Journal of Investigative Dermatology. 130(2). 455–463. 11 indexed citations
14.
Kamp, Søren, Gregor B. E. Jemec, Kåre Kemp, et al.. (2009). Application of stereology to dermatological research. Experimental Dermatology. 18(12). 1001–1009. 13 indexed citations
15.
Jemec, Gregor B. E., et al.. (2008). Teledermatology on the Faroe Islands. International Journal of Dermatology. 47(9). 891–893. 14 indexed citations
16.
Stenderup, Karin, Cecilia Rosada, & Tomas Norman Dam. (2008). [Interleukin-20--a new target in psoriasis treatment].. PubMed. 170(36). 2777–81. 1 indexed citations
17.
Stenderup, Karin, Cecilia Rosada, Anne Worsaae, Jes Thorn Clausen, & Tomas Norman Dam. (2007). Interleukin‐20 as a Target in Psoriasis Treatment. Annals of the New York Academy of Sciences. 1110(1). 368–381. 23 indexed citations
18.
Friedrich, Markus, Daniel Bock, Sandra Philipp, et al.. (2005). Pan-selectin antagonism improves psoriasis manifestation in mice and man. Archives of Dermatological Research. 297(8). 345–351. 51 indexed citations
19.
Villadsen, Louise S., Janine Schuurman, Frank J. Beurskens, et al.. (2003). Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. Journal of Clinical Investigation. 112(10). 1571–1580. 138 indexed citations
20.
Villadsen, Louise S., Janine Schuurman, Frank J. Beurskens, et al.. (2003). Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. Journal of Clinical Investigation. 112(10). 1571–1580. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna López‐Ferrer Breakdown of academic impact, for papers by Nicholas V.C. Chia Breakdown of academic impact, for papers by Laura F. Morris Breakdown of academic impact, for papers by Emanuela Campalani Breakdown of academic impact, for papers by David Soler Breakdown of academic impact, for papers by Maria Yhr Breakdown of academic impact, for papers by Elyssa Ott Breakdown of academic impact, for papers by Julie Parmentier Breakdown of academic impact, for papers by Dingyao Zhang Breakdown of academic impact, for papers by John C. Minnerly
Rankless by CCL
2026